Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion

COVID-19 caused by SARS-Cov-2 is a devastating infection in patients with hematological malignancies. In 2018, the Lebanese Society of Hematology and Blood Transfusion (LSHBT) updated the guidelines for the management of hematological malignancies in Lebanon. In 2019, it was followed by a second upd...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Ahmad, Noun, Peter, Khalil, Charbel, Taher, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006377/
https://www.ncbi.nlm.nih.gov/pubmed/33791197
http://dx.doi.org/10.3389/fonc.2021.564383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006377/
https://www.ncbi.nlm.nih.gov/pubmed/33791197
http://dx.doi.org/10.3389/fonc.2021.564383

Ejemplares similares